Saturday, May 14, 2022 4:48:56 AM
The art spin-off is stock in a new company. And the regulators don't like it when people start selling those shares. Which is why they are often restricted.
But the preferred shares are shares of the same company. And we can't sell them. It is much the same as a regular stock dividend. Except, we don't know yet what to expect. But FINRA shouldn't give us a hard time on this dividend.
The company probably did well not to disclose anything. Any statement about the value of the dividends and the stock could rally, which could easily be seen as market manipulation by the regulators. Kind of what Elon Musk is doing with his tweets. Blatant market manipulation He'll probably get another $20M fine for it. lol.
---
Recent HERB News
- Form C-AR - Annual Report • Edgar (US Regulatory) • 02/26/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 08:51:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 07:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM